Portage Biotech Announces Letter of Intent With Immunova for an Option To Acquire iOx Therapeutics, Ltd
UF startup Immunova, LLC, a private Connecticut-based biotechnology company, has entered into a Letter of Intent with Portage Biotech, Inc. to advance its novel immuno-oncology therapies for cancer treatment.
How Atsena Got Its Gene Therapy To Spread Subretinally To Treat XLRS
UF researcher Sanford Boye, co-founder and adviser of UF Startup Atsena Therapeutics, shared insights into how the company developed its gene therapy to achieve subretinal spread for treating XLRS.
InStore.ai Partners With Loss Prevention Resource Council
InStore.ai, a pioneer in voice-driven business optimization for the retail industry, has entered into a strategic partnership with UF Innovate | Accelerate client Loss Prevention Research Council.
Solid Biosciences Announces Collaboration With Mayo Clinic To Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies
Solid Biosciences Inc., which acquired UF Startup AavantiBio, has partnered with Mayo Clinic to advance an AAV gene therapy platform for next-generation treatments targeting genetic cardiomyopathies and channelopathies linked to sudden cardiac death.
Theft and Crime Are Driving Retail Workers To Look for New Roles, Joint Study From the Loss Prevention Research Council and Verkada Finds
According to research conducted by UF Innovate | Accelerate client Loss Prevention Research Council in collaboration with Verkada, over 40% of retail workers in the U.S. are considering leaving their jobs within the next year due to concerns about personal safety.
RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction
UF Startup RTI Surgical announced the enrollment of the first patient in ADMIRE, a study designed to confirm the safety and effectiveness of Cortiva® Allograft Dermis in implant-based breast reconstruction.
Specnova Launches NovaQSpheres Controlled-Release Beadlet Technology
SpecNova, a UF Innovate | Accelerate graduate, has launched NovaQSpheres, a delivery system offering precision-timed release of ingredients with otherwise short absorption and half-life.
Solid Biosciences To Present at the Jefferies London Healthcare Conference
Solid Biosciences Inc., a biotechnology company that acquired UF startup AavantiBio, announced that Bo Combo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will present at the Jefferies London Healthcare Conference on November 20.
Solid Biosciences Shares Updates on Inspire Duchenne Clinical Trial of SGT-003
Solid Biosciences, a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases that acquired UF startup AavantiBio, shared updates on the INSPIRE DUCHENNE clinical trial for their next-generation AAV micro-dystrophin gene therapy candidate, SGT-003, for the treatment of Duchenne.
Soilcea Modified Sweet Orange Receives Favorable Decision
UF Startup Soilcea’s modified sweet orange, which reportedly has resistance to HLB, has been determined by the U.S. Department of Agriculture Animal and Plant Health Inspection Service (USDA APHIS) to be neither a plant pest nor a plant that requires regulation under 7 CFR part 340.
